IBB News and Press, iShares Biotechnology ETF

2026-07-10 20:00:00 ET By Nick Niziolek, CFA, Dennis Cogan, CFA, Paul Ryndak, CFA, and Kyle Ruge, CFA ... Read the full article on Seeking Alpha For further details see: Global Markets: Fundamentals Have The Floor

2026-07-10 07:01:28 ET Investors seeking exposure to healthcare innovation often have to choose between the stability of established pharmaceutical giants and the higher-growth, higher-risk profile of clinical-stage biotech firms. This comparison looks at the two popular funds -- the iSha...

2026-07-10 02:30:00 ET By Vinay Thapar, CFA & Jane Bleeg Equity investors should cast a wide net to capture the healthcare sector’s full potential. ... Read the full article on Seeking Alpha For further details see: Healthcare Investing: Finding Gr...

2026-07-07 10:28:30 ET Biotech M&A has been scorching hot this year. Big Pharma spent approximately $106 billion on 201 acquisitions in the first half of 2026. If this pace continues, the industry is expected to close more than $250 billion in deal value , placing this as th...

2026-07-04 09:35:03 ET Comparing Vanguard Health Care ETF (NYSEMKT:VHT) and iShares Biotechnology ETF (NASDAQ:IBB) reveals a choice between broad sector diversification and specialized exposure to the high-growth biotechnology niche. Selecting the right vehicle for healt...

2026-07-03 11:35:00 ET Everyone saw the crash and reached for the scariest word. The tape was more specific and more useful. Here’s what actually happened and the fork we’re now standing at.... Read the full article on Seeking Alpha For further details see: ...

2026-07-02 08:05:01 ET Investors seeking broad, low-cost healthcare exposure may prefer State Street Health Care Select Sector SPDR ETF (NYSEMKT:XLV) , while iShares Biotechnology ETF (NASDAQ:IBB) caters to those specifically targeting the high-growth biotechnology subsector...

2026-07-01 12:32:55 ET More on the markets U.S. Treasury Debt Jumps By $3.1 Trillion Since Passage Of The One Big Beautiful Bill Act Markets Taking A Break After Epic Quarter; Crude Falls S&P 500 Risks Bull Trap As Stronger U.S. Dollar Threatens Q2 Rally ...

2026-07-01 12:16:33 ET More on the markets S&P 500 Risks Bull Trap As Stronger U.S. Dollar Threatens Q2 Rally The Symbios Thesis: How I View The Second Winner Of The AI Boom U.S. Dollar Firm Ahead Of ECB Conference And Fed Chair Warsh U.S. stocks mixed at...

2026-07-01 10:20:46 ET Short interest data from late June 2026 highlights deeply divided investor sentiment across the healthcare sector. Strong bearish bets remain heavily concentrated in speculative biotech plays like Recursion Pharmaceuticals ( RXRX ) and Aditxt ( ADTX ...